Skinvisible appoints new international advisory board member

Las Vegas

- Skinvisible has announced the appointment of Geert Cauwenbergh, Ph.D., as the head of its International Advisory Board, MarketWatch reports.

Dr. Cauwenbergh will focus on expanding the demand for Invisicare, a patented polymer delivery system that enhances topically applied products, in international market.

Dr. Cauwenbergh has previously worked in the international dermatology market for the research, development and commercialization of products with Barrier Therapeutics, Johnson and Johnson and Janssen Pharmaceutica.